NARAFLOX

This brand name is authorized in Nigeria.

Active ingredients

The drug NARAFLOX contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA - DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6433	Tablet	Naraflox 500 mg Tablet_ (duplicate) TAB 500 mg 1 x 10's (in Alu Alu blisters)	Film-coated Tablets Red-coloured, Caplet shaped film-coated tablets, plain on both the side. 108 CMS-PP-422040 NARAFLOX 500MG TABLET LEVOFLOXACIN 500MG (levofloxacin 500mg) Microcrystalline Cellulose, Lactose, Carmellose Sodium, Sodium Lauryl Sulfate, Crosspovidone, PVP K-30, Maize Starch, Purified Talc, Colloidal Anhydrous Silica (Aerosil), Magnesium Stearate, Insta Coat Universal (IC-U-1308) (White), Ponceau 4R B4-6433 Drugs Imported Products 1X10 POM 1 4/30/2024 MAYDON PHARMACEUTICAL LIMITED., WILMER STREET, OFF TOWN PLANNING, ILUPEJU, LAGOS LAGOS 1740194511 maydonp@outlook.com MAXHEAL LABORATORIES PVT LTD, PLOT NO. 2-7/80-85 SURSEZ SACHIN DIST. SURAT GUJARAT 394 230 INDIA, India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6433